|
The following stocks are the leading risers and fallers on AIM on Monday. ---------- AIM - WINNERS ---------- Synergia Energy Ltd, up 29% at 0.0225 pence, 12-month range 0.017p-0.1475p. The West Perth, Australia-based oil and gas company says its joint venture partner Selan Exploration has secured a rig and related services from Deep Industries Ltd to drill the first of three new wells under the $20 million work program on the Cambay production sharing contract. Company says it is fully carried by Selan in exchange for a 50% working interest in the Cambay PSC. Says Selan expects drilling to commence in September 2025. Adds that Selan has contracted a 50-tonne workover rig and operations on existing legacy wells will re-start in June. ---------- hVIVO PLC, up 21% at 10.5p, 12-month range 8.7p-30.6p. The London-based contract research organisation, which tests vaccines for infectious and respiratory diseases, says Chief Executive Officer Yasmin Khan purchases 1.1 million shares at 8.9p on Friday, giving her 5.0 million shares, a 0.7% stake. Chief Financial Officer Stephen Pinkerton and spouse Dolores Pinkerton acquire 683,232 shares at 8.76p. They now have 750,596 shares. ---------- AIM - LOSERS ---------- Trellus Health PLC, down 42% at 1.05p, 12-month range 0.525p-4.95p. The London-based healthcare technology company reports a $7.8 million loss for 2024, widened from $6.3 million in 2023. Revenue increases to $114,000 from $19,000, but administrative costs rise to $8.1 million from $6.8 million. Company says it is confident it will be able to achieve further commercial traction. Notes that after the reporting date it enters a contract with Johnson & Johnson Healthcare Systems Inc to support a US patient pilot programme. ‘We have delivered a strong start to 2025, underpinned by the J&J agreement which is an important step forward in our commercialisation strategy and a clear validation of our platform’s potential,’ comments Chief Executive Officer Marla Dubinsky. ‘The pharmaceutical sector remains a core strategic focus for us...The clinical trials sector is another key focus for the company, as we aim to accelerate trial timelines and improve efficiency for our partners, all while driving substantial cost savings.’ ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
